RANI
Rani Therapeutics Holdings-A
NASDAQ · Pharmaceuticals
$1.22
+0.12 (+10.91%)
Open$1.12
Previous Close$1.10
Day High$1.27
Day Low$1.11
52W High$44.44
52W Low$21.37
Volume—
Avg Volume698.1K
Market Cap148.26M
P/E Ratio19.22
EPS$1.70
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+2,945.1% upside
Current
$1.22
$1.22
Target
$37.15
$37.15
$30.65
$37.15 avg
$44.71
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 52.04M | 51.04M | 44.44M |
| Net Income | 7.54M | 8.38M | 6.94M |
| Profit Margin | 14.5% | 16.4% | 15.6% |
| EBITDA | 12.64M | 12.88M | 11.35M |
| Free Cash Flow | 9.62M | 6.14M | 6.76M |
| Rev Growth | +7.1% | +13.5% | +18.6% |
| Debt/Equity | 0.97 | 0.99 | 0.95 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |